SCHEMBL6740390

SCHEMBL6740390

CCN(CC)c1ccc(N=C=O)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 1/20 0.50
ALDH1A1 P00352 7/20 0.44
MAPT P10636 6/20 0.44
RAB9A P51151 3/20 0.44
CYP3A4 P08684 3/20 0.42
TRPA1 O75762 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 2/20 0.41
HSD17B10 Q99714 2/20 0.41
GLA P06280 2/20 0.41
IGLV6-57 P01721 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ATM Q13315 1/20 0.41
HIF1A Q16665 1/20 0.41
TERT O14746 1/20 0.40
S1PR1 P21453 3/20 0.39
NPC1 O15118 1/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315517 0.81 S100B (0.55) S100BALDH1A1MAPTRAB9ACYP3A4
SCHEMBL11024622 0.80 ALDH1A1 (0.59) ALDH1A1MAPTRAB9ACYP3A4L3MBTL1
SCHEMBL24046461 0.77 S100B (0.55) S100BALDH1A1MAPTRAB9ACYP3A4
SCHEMBL9365786 0.75 S100B (0.47) S100BALDH1A1MAPTRAB9ACYP3A4
SCHEMBL3701775 0.75 S100B (0.51) S100BALDH1A1MAPTRAB9ACYP3A4
SCHEMBL11625990 0.74 CYP3A4 (0.40) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL2853713 0.73 ALDH1A1 (0.53) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL420514 0.73 CYP3A4 (0.48) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL31115173 0.72 CYP3A4 (0.52) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL48414 0.72 CYP3A4 (0.58) ALDH1A1MAPTCYP3A4TRPA1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414146-B2 Imaging element containing a blocked photographically useful compound CARESTREAM HEALTH, INC. (US) 2008-08-19 US disclosed
US-7414146-B2 Imaging element containing a blocked photographically useful compound CARESTREAM HEALTH, INC. (US) 2008-08-19 US disclosed
US-6790569-B2 VARIATIONS IN PHOTOSENSITIVITY EASTMAN KODAK COMPANY 2004-09-14 US disclosed
US-6770406-B1 Imaging element containing a polymeric benzylic blocked developer EASTMAN KODAK COMPANY 2004-08-03 US disclosed
US-20040137380-A1 IMAGING ELEMENT CONTAINING A POLYMERIC BENZYLIC BLOCKED DEVELOPER EASTMAN KODAK COMPANY 2004-07-15 US disclosed
US-6749977-B1 PROVIDE GOOD DYE-FORMING ACTIVITY AND WHICH, AT THE SAME TIME, YIELD LITTLE OR NO INCREASED FOG AND/ OR PROVIDE LITTLE OR NO DECREASE IN DMAX AFTER STORAGE EASTMAN KODAK COMPANY 2004-06-15 US disclosed
US-20030129552-A1 Imaging element containing a blocked photographically useful compound SLUSAREK WOJCIECH K (US) 2003-07-10 US disclosed
EP-1295175-A2 PROCESSING OF COLOR PHOTOTHERMOGRAPHIC FILM COMPRISING DRY THERMAL DEVELOPMENT AND WET-CHEMICAL REMEDIATION EASTMAN KODAK COMPANY (US) 2003-03-26 EP disclosed
EP-1295172-A2 COLOR PHOTOTHERMOGRAPHIC ELEMENTS COMPRISING PHENOLIC THERMAL SOLVENTS EASTMAN KODAK COMPANY (US) 2003-03-26 EP disclosed
EP-1295173-A1 PACKAGED COLOR PHOTOGRAPHIC FILM CAPABLE OF ALTERNATIVELY DRY OR WET-CHEMICAL PROCESSING EASTMAN KODAK COMPANY (US) 2003-03-26 EP disclosed
US-20020018967-A1 Processing system for a color photothermographic film comprising dry thermal development and wet-chemical remediation IRVING MARK E (US) 2002-02-14 US disclosed
US-20020018956-A1 Packaged color photographic film capable of alternatively dry or wet-chemical processing LEVY DAVID H (US) 2002-02-14 US disclosed
WO-2001096945-A2 PROCESSING OF COLOR PHOTOTHERMOGRAPHIC FILM COMPRISING DRY THERMAL DEVELOPMENT AND WET-CHEMICAL REMEDIATION EASTMAN KODAK COMPANY (US) 2001-12-20 WO disclosed
WO-2001096950-A1 PACKAGED COLOR PHOTOGRAPHIC FILM CAPABLE OF ALTERNATIVELY DRY OR WET-CHEMICAL PROCESSING EASTMAN KODAK COMPANY (US) 2001-12-20 WO disclosed
WO-2001096943-A2 PROCESSING SYSTEM FOR A COLOR PHOTOTHERMOGRAPHIC FILM COMPRISING DRY THERMAL DEVELOPMENT AND WET-CHEMICAL REMEDIATION EASTMAN KODAK COMPANY (US) 2001-12-20 WO disclosed
WO-2001096947-A2 PROCESSING OF COLOR PHOTOHERMOGRAPHIC ELEMENT COMPRISING DRY THERMAL DEVELOPMENT AND WET CHEMICAL FURTHER PROCESSING EASTMAN KODAK COMPANY (US) 2001-12-20 WO disclosed
WO-2001096944-A2 COLOR PHOTOTHERMOGRAPHIC ELEMENTS COMPRISING PHENOLIC THERMAL SOLVENTS EASTMAN KODAK COMPANY (US) 2001-12-20 WO disclosed
EP-1164418-A2 Color photothermographic elements comprising blocked developing agents EASTMAN KODAK COMPANY (US) 2001-12-19 EP disclosed
EP-1158358-A2 Imaging element containing a blocked photographically useful compound EASTMAN KODAK COMPANY (US) 2001-11-28 EP disclosed
EP-1158359-A2 Imaging element containing a blocked photographically useful compound EASTMAN KODAK COMPANY (US) 2001-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030129552-A1 Imaging element containing a blocked photographically useful compound TBCB, BRI3BP, ABCB4 S100B 1236/4885ALDH1A1 2459/4885MAPT 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.